Viatris Expects First “Interchangeable” Designation in July 2021 For Insulin Products

Publication Date17 May 2021
SubjectPrescription Drugs,Biosimilars,Pharmaceutical Patents,Pharmaceutical Industry,Interchangeability
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT